Urgent call for breast cancer drug to stop women’s lives being cut short

A new study has enabled scientists to study breast tissue in detail outside the body (Rui Vieira/PA) (PA Wire)

An urgent warning has been made to health officials and pharmaceutical companies to work together to make a life-extending drug available to thousands of women with incurable breast cancer.

Experts from Breast Cancer Now said that women’s lives “will be cut short” with further delays as they called for Enhertu to be made available to women in England with a certain type of breast cancer as swiftly as possible.

In March it was announced that the treatment was blocked for widespread NHS use for women with HER2-low incurable secondary breast cancer due to price issues.

The National Institute for Health and Care Excellence (Nice) said the cost the NHS was being asked to pay for trastuzumab deruxtecan – sold under the brand name Enhertu – was “too high” in relation to its benefits.

A quarter of a million people signed a petition calling for an “urgent solution” to get the treatment to women living with secondary breast cancer as soon as possible.

Enhertu is the first licensed targeted treatment for patients with HER2-low breast cancer that cannot be removed surgically or that has spread to other parts of the body, also known as metastatic breast cancer.

Breast Cancer Now said that the drugs offer women six more months to live.

breast cancer, disease, women, urgent call for breast cancer drug to stop women’s lives being cut short
A radiologist uses a magnifying glass to check mammograms for breast cancer (Copyright 2019 The Associated Press. All rights reserved.)

Women with HER2-low incurable secondary disease in Scotland currently have access to the drug, while others across the UK do not, the charity said.

Had Nice recommended the treatment, about 1,000 patients a year would have been eligible.

Baroness Delyth Morgan, chief executive at Breast Cancer Now, said: “Over a quarter of a million people have signed our Enhertu Emergency petition, rallying behind us and keeping up pressure and momentum in calling on Nice, NHS England, Daiichi Sankyo and AstraZeneca to get back around the table to reach a solution to ensure Enhertu is made available on the NHS in England for women who desperately need it.

“This must happen urgently, or women’s lives will tragically be cut short.”

Draft guidance published by Nice in September said it would not recommend Enhertu for NHS use in England due to uncertainties in the information provided by the manufacturer and called for more details.

The spending watchdog then paused its appraisal in December while commercial talks were ongoing with pharmaceutical companies Daiichi Sankyo and AstraZeneca, but in March it was announced that the talks concluded without a price agreement in place.

Breast Cancer Now said that health leaders and pharmaceutical companies should “seize the opportunity presented by the delay to Nice’s final guidance being published” to find a solution.

It is understood that talks between parties have resumed.

A letter from NHS officials sent to MPs on the parliamentary Health Committee on Tuesday stated: “We can confirm that a further discussion with all relevant parties was held on 15th May, with an expectation of flexibility from all sides. However, at this meeting Daiichi Sankyo informed us of the withdrawal of its previous commercial offer and increased the price proposal for the drug.”

Lady Morgan added: “Nice’s delay to the publication of its final guidance on Enhertu creates a crucial window of opportunity for this heart-breaking situation to be fixed now, and women with HER2-low secondary breast cancer to be granted precious hope of more time to live and to create special moments that matter.”

breast cancer, disease, women, urgent call for breast cancer drug to stop women’s lives being cut short
NHS nurse Tracy Pratt whowas diagnosed with HER2-low secondary breast cancer in November 2022 after experiencing upper back pain (Breast Cancer Now/PA Wire)

NHS nurse Tracy Pratt was diagnosed with HER2-low secondary breast cancer in November 2022 after experiencing upper back pain.

The 52-year-old from Tydd St Mary, Lincolnshire, said: “When I heard the news that it had been rejected for use on the NHS, I was in shock.

“I cried, I felt completely let down and lost, sad for me, sad for my family and sad for everyone else in the secondary breast cancer community, that this decision affects.

“Enhertu would give me more quality time to enjoy my life with my family and friends, more time to live with secondary breast cancer. It would give me more time to travel and continue to work as a nurse. Ultimately it would give me hope.

“This decision does not just affect us living with secondary breast cancer now but also those that will develop it in the future. The reality is that the decision is likely to affect you or someone you love in the future. This decision must be reversed.”

A spokesperson for Daiichi Sankyo said: “Daiichi Sankyo and AstraZeneca welcomed the opportunity to provide evidence to the Health and Social Care Committee and All Party Parliamentary Group on Breast Cancer regarding Nice’s decision to not recommend Enhertu for HER2-low metastatic breast cancer, as well as highlight our concerns regarding the impact of changes to Nice’s formula on the future launch of treatments targeting late-stage cancers.

“As committed to during the meeting we have restarted the dialogue with NHS England and Nice, and the final publication of guidance has been paused while those talks are ongoing.”

OTHER NEWS

22 minutes ago

GT Aston Martin Exits Le Mans In a Dramatic Rollover Crash

22 minutes ago

Fernando Alonso knows the moment it will be ‘bye bye’ from F1 for good

28 minutes ago

The Tory manifesto raises more questions than answers – here are 20 of the biggest

28 minutes ago

'This film is about a survivor': Alicia Vikander on playing Katherine Parr

28 minutes ago

Controversial finish in Collingwood and North Melbourne game, as Bobby Hill takes MOTY contender, and Giants down Power

28 minutes ago

THR Frontrunners Q&A With the Cast and Creators of 'Young Sheldon' | THR Video

28 minutes ago

'We'll hunt you': Trump, MAGA supporters' violent rhetoric isn't a glitch. It's a feature.

28 minutes ago

The big lie: why taxes are going up (no matter what the Tories or Labour say)

28 minutes ago

‘Star of the show’: DeChambeau firmly in driver’s seat to win second U.S. Open

28 minutes ago

‘Keep the coaches, change entire team’: Wasim Akram wants all players of Babar Azam-led Pakistan squad dropped

28 minutes ago

Donald Trump challenges Joe Biden to cognitive test but then forgets name of his own doctor

28 minutes ago

Lady Elliot Island boat capsize: Desperate search for missing man after boat overturned ends in tragedy off Queensland coast near Bundaberg after Life Flight winched a father and son to safety

31 minutes ago

Ashley Graham debuts children's book encouraging self-love, confidence

35 minutes ago

Video: Hundreds of Majorcans take over tiny picture postcard cove made famous by Instagram 'influencers' and unfurl banners reading 'SOS Residents' amid Spanish island's anti-tourism backlash against UK holidaymakers

35 minutes ago

Ukraine proves it can target the Russian air force's weakest link

35 minutes ago

Canada cricketers miss out on marquee matchup with India due to wet ground conditions

35 minutes ago

Luai praised as Origin awaits

35 minutes ago

'Good to go': Edwards, Luai shine in final NSW audition

35 minutes ago

Down 10% in a week! What’s wrong with the Legal & General Group share price?

35 minutes ago

Gary Neville hammered after naming England XI Southgate MUST pick for Euro 2024 opener

35 minutes ago

'Prison-cell' flat that costs £475 a month is like a sit-com set

35 minutes ago

Ox Nche makes the cut as Bulls dominate URC Team of the Season

35 minutes ago

Israel announces ‘pause’ along southern Gaza route to allow in aid but no let up in Rafah offensive

39 minutes ago

Thorpe Park’s Hyperia rollercoaster breaks down again leaving thrillseekers hanging at 236ft

40 minutes ago

Woman who spent 43 years behind bars has murder conviction overturned

40 minutes ago

"Pogacar seems unbeatable, so we must aim for stage victories": What can EF-boys Powless and Van den Berg pull off in the Tour?

40 minutes ago

Samantha Murphy: Cop makes bleak admission about the endless search for missing Ballarat mum after discovery by a dam renewed hopes of finding her body

40 minutes ago

Video: Married At First Sight's Martha Kalifatidis and Michael Brunelli's one-year-old son Lucius shares first words

40 minutes ago

Video: All the best videos from Trooping the Colour: Kate's great comeback, glimpses behind the scenes and Charlotte and Louis acting up

46 minutes ago

Sex attacker dubbed 'Coronation Street rapist' launches NEW parole bid - despite breaking rules when he was last released from jail

46 minutes ago

Jobless man, 60, who still lives with his mother smashed woman's windscreen with his fists in fit of rage after she turned her car around in his driveway

46 minutes ago

From AI-powered limb-tracking to a match ball with a chip inside: The futuristic technologies powering Euro 2024 in Germany this month, revealed

46 minutes ago

NASA's Chandra X-ray telescope captures closest super star cluster to Earth (image)

49 minutes ago

Happy Father's Day! Amanda Holden and Charlotte Crosby lead the stars marking the occasion with sweet family snaps and heartfelt tributes

51 minutes ago

Ben Johnson to Snub Crystal Palace and Stay at West Ham

51 minutes ago

Alan Shearer spots England's biggest problem at Euro 2024 as he names ideal starting XI

51 minutes ago

England faces Serbia in Euro 2024 group opener aiming to end 58 years of hurt

51 minutes ago

Koeman shrugs off hiccups and insists Netherlands have fighting chance

51 minutes ago

Why 'The Apprentice' Filmmakers Have Not Yet Secured a US Distribution Deal | Analysis

52 minutes ago

Married At First Sight's Martha Kalifatidis and Michael Brunelli's one-year-old son Lucius shares first words